| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 25 | 2025 | 583 | 2.720 |
Why?
|
| Military Personnel | 14 | 2024 | 109 | 1.770 |
Why?
|
| Tobacco Use Disorder | 11 | 2022 | 249 | 1.420 |
Why?
|
| Female | 132 | 2025 | 24018 | 1.320 |
Why?
|
| Humans | 172 | 2025 | 42163 | 1.290 |
Why?
|
| Adult | 91 | 2025 | 13458 | 1.250 |
Why?
|
| Overweight | 13 | 2024 | 248 | 1.240 |
Why?
|
| Obesity | 25 | 2024 | 1131 | 1.160 |
Why?
|
| Young Adult | 54 | 2025 | 4936 | 1.120 |
Why?
|
| Adolescent | 53 | 2025 | 5950 | 1.040 |
Why?
|
| Pregnancy Complications | 7 | 2024 | 134 | 1.040 |
Why?
|
| Smoking | 16 | 2021 | 1019 | 1.040 |
Why?
|
| Male | 103 | 2025 | 22779 | 1.020 |
Why?
|
| Weight Loss | 14 | 2024 | 138 | 0.990 |
Why?
|
| Logistic Models | 14 | 2021 | 1001 | 0.970 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 55 | 0.920 |
Why?
|
| United States | 46 | 2025 | 5072 | 0.860 |
Why?
|
| Cannabis | 2 | 2023 | 90 | 0.820 |
Why?
|
| Cross-Sectional Studies | 36 | 2025 | 3077 | 0.810 |
Why?
|
| Middle Aged | 61 | 2025 | 11819 | 0.760 |
Why?
|
| Veterans | 5 | 2019 | 203 | 0.740 |
Why?
|
| Pregnancy | 22 | 2024 | 1737 | 0.740 |
Why?
|
| Weight Gain | 11 | 2024 | 138 | 0.710 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2023 | 744 | 0.690 |
Why?
|
| Product Labeling | 3 | 2025 | 7 | 0.650 |
Why?
|
| Arkansas | 24 | 2021 | 43 | 0.630 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2022 | 959 | 0.630 |
Why?
|
| Directive Counseling | 2 | 2010 | 16 | 0.620 |
Why?
|
| Prevalence | 19 | 2024 | 1597 | 0.610 |
Why?
|
| Aged | 42 | 2024 | 7982 | 0.600 |
Why?
|
| Body Mass Index | 17 | 2025 | 916 | 0.600 |
Why?
|
| Life Change Events | 1 | 2019 | 107 | 0.590 |
Why?
|
| Healthcare Disparities | 6 | 2025 | 573 | 0.580 |
Why?
|
| Adaptation, Psychological | 3 | 2020 | 410 | 0.550 |
Why?
|
| Rural Population | 6 | 2022 | 352 | 0.540 |
Why?
|
| Adolescent Behavior | 6 | 2021 | 270 | 0.540 |
Why?
|
| Pre-Eclampsia | 4 | 2023 | 68 | 0.540 |
Why?
|
| Alcohol Drinking | 5 | 2022 | 585 | 0.530 |
Why?
|
| Premature Birth | 3 | 2023 | 94 | 0.520 |
Why?
|
| Health Behavior | 11 | 2021 | 568 | 0.520 |
Why?
|
| Infant, Newborn | 11 | 2024 | 960 | 0.500 |
Why?
|
| Life Style | 7 | 2025 | 326 | 0.500 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 825 | 0.490 |
Why?
|
| Hotlines | 3 | 2017 | 16 | 0.490 |
Why?
|
| Patient Education as Topic | 5 | 2021 | 234 | 0.490 |
Why?
|
| Florida | 11 | 2025 | 461 | 0.480 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2025 | 358 | 0.480 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 680 | 0.470 |
Why?
|
| Marijuana Smoking | 3 | 2023 | 90 | 0.460 |
Why?
|
| Risk Factors | 24 | 2025 | 3942 | 0.450 |
Why?
|
| Mass Screening | 8 | 2018 | 531 | 0.440 |
Why?
|
| Apolipoprotein E4 | 2 | 2025 | 62 | 0.430 |
Why?
|
| Vaccination | 3 | 2025 | 332 | 0.430 |
Why?
|
| HIV Infections | 6 | 2025 | 2535 | 0.420 |
Why?
|
| Cognition | 3 | 2025 | 458 | 0.420 |
Why?
|
| Preventive Health Services | 2 | 2018 | 65 | 0.410 |
Why?
|
| Dysphonia | 3 | 2020 | 5 | 0.410 |
Why?
|
| Students | 6 | 2025 | 617 | 0.410 |
Why?
|
| Hepatitis C | 2 | 2025 | 138 | 0.410 |
Why?
|
| Amputees | 2 | 2023 | 12 | 0.390 |
Why?
|
| Artificial Limbs | 2 | 2023 | 12 | 0.390 |
Why?
|
| Diabetes Mellitus | 6 | 2020 | 532 | 0.380 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 245 | 0.380 |
Why?
|
| Self Efficacy | 4 | 2022 | 211 | 0.380 |
Why?
|
| Indians, North American | 3 | 2005 | 179 | 0.370 |
Why?
|
| Exercise | 7 | 2025 | 674 | 0.360 |
Why?
|
| Cross-Over Studies | 4 | 2025 | 112 | 0.360 |
Why?
|
| Secondary Prevention | 2 | 2010 | 47 | 0.360 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2019 | 471 | 0.360 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 174 | 0.360 |
Why?
|
| Iodoacetates | 1 | 2010 | 2 | 0.340 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2010 | 15 | 0.340 |
Why?
|
| Early Detection of Cancer | 4 | 2018 | 428 | 0.340 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2022 | 20 | 0.340 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 2010 | 18 | 0.340 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 242 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 225 | 0.330 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 28 | 0.330 |
Why?
|
| Body Weight | 5 | 2024 | 428 | 0.330 |
Why?
|
| Health Policy | 5 | 2021 | 184 | 0.330 |
Why?
|
| Health Surveys | 8 | 2024 | 401 | 0.320 |
Why?
|
| Advisory Committees | 2 | 2019 | 34 | 0.320 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2020 | 8 | 0.320 |
Why?
|
| Socioeconomic Factors | 13 | 2025 | 1221 | 0.310 |
Why?
|
| Nicotine | 4 | 2024 | 290 | 0.310 |
Why?
|
| Acculturation | 2 | 2022 | 203 | 0.310 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2012 | 350 | 0.310 |
Why?
|
| Carotid Artery, Common | 4 | 2013 | 9 | 0.300 |
Why?
|
| Colorectal Neoplasms | 4 | 2018 | 502 | 0.290 |
Why?
|
| Health Education | 7 | 2015 | 358 | 0.290 |
Why?
|
| Retrospective Studies | 12 | 2024 | 2485 | 0.290 |
Why?
|
| Birth Weight | 4 | 2022 | 94 | 0.290 |
Why?
|
| Postpartum Period | 3 | 2024 | 91 | 0.290 |
Why?
|
| Depression | 2 | 2025 | 837 | 0.270 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 93 | 0.260 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 126 | 0.250 |
Why?
|
| Cohort Studies | 9 | 2020 | 1729 | 0.250 |
Why?
|
| Longitudinal Studies | 8 | 2023 | 1020 | 0.250 |
Why?
|
| Gestational Age | 3 | 2022 | 195 | 0.250 |
Why?
|
| Body Water | 2 | 2023 | 25 | 0.250 |
Why?
|
| Family Planning Services | 3 | 2012 | 34 | 0.250 |
Why?
|
| Schools | 5 | 2020 | 283 | 0.250 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 188 | 0.250 |
Why?
|
| Drinking | 2 | 2023 | 35 | 0.250 |
Why?
|
| Models, Biological | 2 | 2010 | 711 | 0.240 |
Why?
|
| Child | 12 | 2025 | 3381 | 0.240 |
Why?
|
| Religion | 2 | 2018 | 90 | 0.240 |
Why?
|
| Body Composition | 2 | 2025 | 160 | 0.240 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 54 | 0.240 |
Why?
|
| Hypertension | 4 | 2021 | 823 | 0.240 |
Why?
|
| Infant | 4 | 2022 | 1143 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 40 | 0.240 |
Why?
|
| Breast Neoplasms | 6 | 2017 | 1679 | 0.240 |
Why?
|
| Poliomyelitis | 1 | 2005 | 7 | 0.230 |
Why?
|
| Receptors, GABA | 1 | 2025 | 28 | 0.230 |
Why?
|
| Intention | 2 | 2024 | 103 | 0.230 |
Why?
|
| Environmental Exposure | 3 | 2020 | 247 | 0.230 |
Why?
|
| Spheroids, Cellular | 1 | 2005 | 37 | 0.230 |
Why?
|
| Referral and Consultation | 3 | 2010 | 141 | 0.230 |
Why?
|
| Health Status | 3 | 2014 | 432 | 0.230 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 729 | 0.220 |
Why?
|
| Community-Based Participatory Research | 5 | 2018 | 336 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 268 | 0.220 |
Why?
|
| Skin | 3 | 2012 | 185 | 0.220 |
Why?
|
| Comparative Effectiveness Research | 3 | 2019 | 15 | 0.220 |
Why?
|
| Workplace | 1 | 2025 | 86 | 0.220 |
Why?
|
| Patient Preference | 1 | 2024 | 55 | 0.220 |
Why?
|
| Bone Density | 1 | 2025 | 102 | 0.220 |
Why?
|
| Soil Pollutants | 3 | 2012 | 104 | 0.220 |
Why?
|
| Epilepsy | 1 | 2024 | 56 | 0.220 |
Why?
|
| Perception | 4 | 2018 | 209 | 0.210 |
Why?
|
| Patient Compliance | 6 | 2012 | 225 | 0.210 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2010 | 90 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2006 | 164 | 0.210 |
Why?
|
| Healthy People Programs | 1 | 2003 | 25 | 0.210 |
Why?
|
| Vulnerable Populations | 1 | 2025 | 163 | 0.210 |
Why?
|
| Diet | 4 | 2025 | 810 | 0.210 |
Why?
|
| Uterine Rupture | 1 | 2023 | 5 | 0.210 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 137 | 0.200 |
Why?
|
| Stroke | 2 | 2021 | 348 | 0.200 |
Why?
|
| Aged, 80 and over | 8 | 2023 | 2803 | 0.200 |
Why?
|
| Pilot Projects | 7 | 2024 | 733 | 0.200 |
Why?
|
| Microglia | 1 | 2025 | 204 | 0.200 |
Why?
|
| Telephone | 4 | 2022 | 35 | 0.200 |
Why?
|
| Information Dissemination | 2 | 2021 | 66 | 0.200 |
Why?
|
| Employment | 2 | 2022 | 83 | 0.190 |
Why?
|
| Stress, Psychological | 3 | 2022 | 641 | 0.190 |
Why?
|
| Minority Groups | 2 | 2025 | 663 | 0.190 |
Why?
|
| Counseling | 3 | 2020 | 134 | 0.190 |
Why?
|
| Child Abuse | 1 | 2023 | 90 | 0.190 |
Why?
|
| Neoplasms | 2 | 2010 | 1341 | 0.180 |
Why?
|
| Fetal Macrosomia | 1 | 2021 | 12 | 0.180 |
Why?
|
| Self Care | 4 | 2021 | 173 | 0.180 |
Why?
|
| Medicaid | 3 | 2020 | 138 | 0.180 |
Why?
|
| Sleep | 2 | 2025 | 179 | 0.180 |
Why?
|
| Administrative Personnel | 1 | 2021 | 11 | 0.180 |
Why?
|
| Risk Assessment | 7 | 2020 | 845 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 14 | 0.170 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 26 | 0.170 |
Why?
|
| Research Design | 4 | 2017 | 370 | 0.170 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2020 | 5 | 0.170 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 22 | 0.170 |
Why?
|
| Ambulatory Care | 2 | 2019 | 81 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 638 | 0.170 |
Why?
|
| Fetal Weight | 1 | 2020 | 9 | 0.170 |
Why?
|
| Meditation | 1 | 2021 | 25 | 0.170 |
Why?
|
| Yoga | 1 | 2021 | 33 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 22 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2022 | 1574 | 0.170 |
Why?
|
| Food Services | 2 | 2011 | 31 | 0.170 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 50 | 0.170 |
Why?
|
| Brain Chemistry | 1 | 2020 | 140 | 0.170 |
Why?
|
| Reminder Systems | 2 | 2018 | 15 | 0.160 |
Why?
|
| Nutrition Policy | 2 | 2011 | 64 | 0.160 |
Why?
|
| Behavior Therapy | 2 | 2012 | 179 | 0.160 |
Why?
|
| Yolk Sac | 1 | 2020 | 4 | 0.160 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 48 | 0.160 |
Why?
|
| Primary Health Care | 2 | 2016 | 362 | 0.160 |
Why?
|
| Voice Training | 1 | 2019 | 1 | 0.160 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 1051 | 0.160 |
Why?
|
| Tooth Extraction | 1 | 2019 | 5 | 0.160 |
Why?
|
| Transients and Migrants | 1 | 2020 | 42 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 13 | 0.160 |
Why?
|
| Contraception Behavior | 1 | 2020 | 33 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 28 | 0.160 |
Why?
|
| Brain | 2 | 2025 | 1452 | 0.160 |
Why?
|
| Flavoring Agents | 1 | 2019 | 22 | 0.150 |
Why?
|
| Social Support | 2 | 2019 | 438 | 0.150 |
Why?
|
| Physicians | 2 | 2019 | 180 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 154 | 0.150 |
Why?
|
| Culture | 2 | 2018 | 172 | 0.150 |
Why?
|
| Floors and Floorcoverings | 2 | 2009 | 3 | 0.150 |
Why?
|
| Public Health | 2 | 2021 | 405 | 0.150 |
Why?
|
| Age Distribution | 7 | 2021 | 249 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 33 | 0.150 |
Why?
|
| Uterine Artery | 1 | 2018 | 2 | 0.150 |
Why?
|
| Motivation | 4 | 2025 | 492 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 45 | 0.150 |
Why?
|
| Blood Pressure | 2 | 2021 | 662 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 66 | 0.140 |
Why?
|
| Fees, Pharmaceutical | 1 | 2018 | 3 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 88 | 0.140 |
Why?
|
| Mandatory Programs | 1 | 2018 | 5 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 188 | 0.140 |
Why?
|
| Health Promotion | 5 | 2022 | 691 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 26 | 0.140 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 172 | 0.140 |
Why?
|
| Lebanon | 3 | 2024 | 20 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2018 | 541 | 0.140 |
Why?
|
| Fetal Heart | 1 | 2017 | 4 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2019 | 180 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 972 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2012 | 245 | 0.140 |
Why?
|
| Interviews as Topic | 4 | 2008 | 428 | 0.140 |
Why?
|
| Fetal Development | 1 | 2017 | 34 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2018 | 108 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2013 | 705 | 0.130 |
Why?
|
| Treatment Outcome | 8 | 2021 | 1586 | 0.130 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 250 | 0.130 |
Why?
|
| Soil | 2 | 2009 | 170 | 0.130 |
Why?
|
| Food Supply | 1 | 2018 | 120 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2018 | 461 | 0.130 |
Why?
|
| Immunization Schedule | 1 | 2016 | 9 | 0.130 |
Why?
|
| Carotid Artery Diseases | 2 | 2008 | 25 | 0.130 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2016 | 4 | 0.130 |
Why?
|
| Tobacco Industry | 1 | 2016 | 9 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2016 | 31 | 0.130 |
Why?
|
| Oklahoma | 4 | 2005 | 28 | 0.130 |
Why?
|
| Immunization | 1 | 2016 | 93 | 0.130 |
Why?
|
| Voice Quality | 2 | 2019 | 5 | 0.130 |
Why?
|
| Community Health Services | 3 | 2012 | 207 | 0.120 |
Why?
|
| Length of Stay | 2 | 2015 | 231 | 0.120 |
Why?
|
| Blood Glucose | 3 | 2019 | 386 | 0.120 |
Why?
|
| Dextropropoxyphene | 1 | 2015 | 1 | 0.120 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 1 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 512 | 0.120 |
Why?
|
| Ethanol | 1 | 2017 | 221 | 0.120 |
Why?
|
| Urban Population | 1 | 2017 | 364 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2013 | 57 | 0.110 |
Why?
|
| Universities | 4 | 2025 | 539 | 0.110 |
Why?
|
| Data Collection | 3 | 2015 | 210 | 0.110 |
Why?
|
| Ultrasonography | 4 | 2008 | 132 | 0.110 |
Why?
|
| Program Development | 2 | 2013 | 237 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 107 | 0.110 |
Why?
|
| Beverages | 2 | 2023 | 65 | 0.110 |
Why?
|
| Incidence | 5 | 2020 | 1054 | 0.110 |
Why?
|
| Family | 1 | 2015 | 192 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2015 | 131 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2010 | 1420 | 0.100 |
Why?
|
| Urinary Catheterization | 1 | 2013 | 4 | 0.100 |
Why?
|
| Catheters, Indwelling | 1 | 2013 | 9 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2015 | 158 | 0.100 |
Why?
|
| Safety | 1 | 2014 | 51 | 0.100 |
Why?
|
| Urinary Incontinence | 1 | 2013 | 15 | 0.100 |
Why?
|
| Program Evaluation | 5 | 2012 | 358 | 0.100 |
Why?
|
| Time and Motion Studies | 2 | 2023 | 13 | 0.100 |
Why?
|
| Housing | 1 | 2014 | 68 | 0.100 |
Why?
|
| Quality of Life | 3 | 2023 | 599 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2015 | 120 | 0.100 |
Why?
|
| Prenatal Care | 2 | 2024 | 82 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2013 | 55 | 0.100 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 26 | 0.100 |
Why?
|
| Lower Extremity | 2 | 2023 | 36 | 0.100 |
Why?
|
| Aluminum | 2 | 2012 | 39 | 0.100 |
Why?
|
| Postural Balance | 2 | 2023 | 37 | 0.100 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2022 | 77 | 0.100 |
Why?
|
| Carbon Monoxide | 2 | 2025 | 48 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 438 | 0.100 |
Why?
|
| Proton Pump Inhibitors | 1 | 2012 | 16 | 0.100 |
Why?
|
| Rural Health Services | 1 | 2012 | 47 | 0.100 |
Why?
|
| Alcoholism | 1 | 2016 | 292 | 0.100 |
Why?
|
| Ticlopidine | 1 | 2012 | 17 | 0.100 |
Why?
|
| Echocardiography | 1 | 2013 | 167 | 0.090 |
Why?
|
| After-Hours Care | 1 | 2012 | 5 | 0.090 |
Why?
|
| Peer Group | 2 | 2016 | 173 | 0.090 |
Why?
|
| Dioxins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Aluminum Silicates | 1 | 2012 | 7 | 0.090 |
Why?
|
| Preconception Care | 1 | 2012 | 10 | 0.090 |
Why?
|
| Ceramics | 1 | 2012 | 6 | 0.090 |
Why?
|
| Genotype | 2 | 2025 | 796 | 0.090 |
Why?
|
| Tobacco, Smokeless | 3 | 2016 | 19 | 0.090 |
Why?
|
| Mental Healing | 1 | 2011 | 2 | 0.090 |
Why?
|
| Patient Admission | 1 | 2012 | 50 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 77 | 0.090 |
Why?
|
| Continuity of Patient Care | 2 | 2010 | 118 | 0.090 |
Why?
|
| Child Behavior | 2 | 2009 | 81 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2021 | 238 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 850 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2012 | 89 | 0.090 |
Why?
|
| Lead Poisoning | 1 | 2011 | 25 | 0.090 |
Why?
|
| Nutrition Assessment | 1 | 2011 | 79 | 0.090 |
Why?
|
| Occupational Diseases | 1 | 2011 | 53 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 12 | 0.090 |
Why?
|
| Viral Load | 2 | 2022 | 344 | 0.090 |
Why?
|
| Speech Production Measurement | 1 | 2010 | 2 | 0.090 |
Why?
|
| Bupropion | 2 | 2023 | 13 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 121 | 0.080 |
Why?
|
| Age Factors | 4 | 2019 | 1139 | 0.080 |
Why?
|
| Disease Progression | 2 | 2010 | 661 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 216 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2012 | 206 | 0.080 |
Why?
|
| Internet | 1 | 2012 | 234 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 48 | 0.080 |
Why?
|
| Refractive Errors | 1 | 2010 | 30 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 21 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 55 | 0.080 |
Why?
|
| Environmental Monitoring | 2 | 2009 | 226 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 39 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 92 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 60 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 87 | 0.080 |
Why?
|
| Odds Ratio | 4 | 2013 | 587 | 0.080 |
Why?
|
| Legislation, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 41 | 0.080 |
Why?
|
| Emigrants and Immigrants | 1 | 2011 | 156 | 0.080 |
Why?
|
| Intelligence | 1 | 2009 | 14 | 0.080 |
Why?
|
| Agonistic Behavior | 1 | 2008 | 2 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2010 | 230 | 0.070 |
Why?
|
| Communication | 2 | 2021 | 207 | 0.070 |
Why?
|
| Stereotyping | 1 | 2009 | 45 | 0.070 |
Why?
|
| Tennessee | 2 | 2020 | 88 | 0.070 |
Why?
|
| Poverty | 1 | 2012 | 395 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 708 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 602 | 0.070 |
Why?
|
| Prejudice | 1 | 2009 | 116 | 0.070 |
Why?
|
| Sex Factors | 4 | 2017 | 1008 | 0.070 |
Why?
|
| Time Factors | 4 | 2017 | 1848 | 0.070 |
Why?
|
| Recurrence | 2 | 2019 | 149 | 0.070 |
Why?
|
| Organizational Policy | 1 | 2007 | 26 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2007 | 39 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2008 | 98 | 0.070 |
Why?
|
| Acetaminophen | 2 | 2019 | 28 | 0.070 |
Why?
|
| School Health Services | 1 | 2008 | 89 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2007 | 336 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 45 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 508 | 0.070 |
Why?
|
| Computer Simulation | 3 | 2021 | 404 | 0.070 |
Why?
|
| Animals | 4 | 2025 | 16695 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 438 | 0.070 |
Why?
|
| Mice | 2 | 2025 | 6490 | 0.060 |
Why?
|
| Dietary Sucrose | 1 | 2006 | 17 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2015 | 336 | 0.060 |
Why?
|
| Glioma | 1 | 2007 | 92 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2007 | 97 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2007 | 52 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2016 | 224 | 0.060 |
Why?
|
| Cultural Competency | 1 | 2008 | 137 | 0.060 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2006 | 2 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2007 | 154 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 93 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 129 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 170 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 138 | 0.060 |
Why?
|
| Anger | 1 | 2025 | 27 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 222 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 164 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1266 | 0.060 |
Why?
|
| Morbidity | 2 | 2018 | 97 | 0.060 |
Why?
|
| Occult Blood | 2 | 2017 | 32 | 0.060 |
Why?
|
| Peru | 1 | 2024 | 40 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2025 | 44 | 0.060 |
Why?
|
| Organ Size | 2 | 2020 | 167 | 0.060 |
Why?
|
| Heterozygote | 1 | 2024 | 107 | 0.050 |
Why?
|
| Parents | 1 | 2008 | 359 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2019 | 1516 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2024 | 73 | 0.050 |
Why?
|
| Self Concept | 1 | 2025 | 170 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 1058 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 506 | 0.050 |
Why?
|
| ROC Curve | 2 | 2018 | 157 | 0.050 |
Why?
|
| Drug Users | 1 | 2024 | 51 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2024 | 124 | 0.050 |
Why?
|
| Texas | 1 | 2025 | 428 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2023 | 39 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2012 | 487 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2598 | 0.050 |
Why?
|
| Urinalysis | 1 | 2023 | 34 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 121 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 658 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 2024 | 196 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 534 | 0.050 |
Why?
|
| India | 1 | 2022 | 105 | 0.050 |
Why?
|
| Educational Status | 3 | 2009 | 335 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2018 | 574 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 362 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 36 | 0.050 |
Why?
|
| New York | 2 | 2011 | 88 | 0.040 |
Why?
|
| Vital Signs | 1 | 2021 | 1 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2024 | 325 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 253 | 0.040 |
Why?
|
| Iran | 1 | 2021 | 199 | 0.040 |
Why?
|
| Mammography | 1 | 2002 | 211 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2021 | 37 | 0.040 |
Why?
|
| Alabama | 2 | 2012 | 52 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2013 | 162 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 11 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 108 | 0.040 |
Why?
|
| Water | 1 | 2023 | 314 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2012 | 152 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 764 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 78 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2003 | 456 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 37 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 115 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 21 | 0.040 |
Why?
|
| Muscle Tonus | 1 | 2019 | 6 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2019 | 34 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1554 | 0.040 |
Why?
|
| Lead | 1 | 2020 | 101 | 0.040 |
Why?
|
| New York City | 2 | 2012 | 283 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 74 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2019 | 23 | 0.040 |
Why?
|
| Contraception | 1 | 2020 | 60 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 78 | 0.040 |
Why?
|
| Micronesia | 1 | 2019 | 87 | 0.040 |
Why?
|
| Skin Absorption | 2 | 2009 | 15 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 2024 | 483 | 0.040 |
Why?
|
| Apgar Score | 1 | 2018 | 5 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2018 | 16 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 28 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 47 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 54 | 0.040 |
Why?
|
| Uterus | 1 | 2018 | 57 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2018 | 93 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 78 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 2017 | 3 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 8 | 0.030 |
Why?
|
| Papio | 1 | 2017 | 22 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2017 | 11 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 236 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 24 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 184 | 0.030 |
Why?
|
| Fruit | 2 | 2011 | 178 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2017 | 58 | 0.030 |
Why?
|
| Educational Measurement | 2 | 2009 | 100 | 0.030 |
Why?
|
| Rural Health | 1 | 2017 | 55 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 176 | 0.030 |
Why?
|
| Child Health Services | 1 | 2016 | 42 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 353 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 183 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 366 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 177 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 33 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 990 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.030 |
Why?
|
| Social Environment | 1 | 2016 | 218 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 311 | 0.030 |
Why?
|
| Ventilation | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sanitation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Water Supply | 1 | 2014 | 59 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 847 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3701 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2012 | 48 | 0.020 |
Why?
|
| Electric Countershock | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 206 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 191 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 9 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2012 | 5 | 0.020 |
Why?
|
| Contraceptive Agents | 1 | 2012 | 13 | 0.020 |
Why?
|
| Computer Systems | 1 | 2012 | 19 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 13 | 0.020 |
Why?
|
| Hawaii | 1 | 2018 | 2004 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 151 | 0.020 |
Why?
|
| Health Educators | 1 | 2011 | 5 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2012 | 43 | 0.020 |
Why?
|
| Sex Education | 1 | 2012 | 36 | 0.020 |
Why?
|
| Menu Planning | 1 | 2011 | 8 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 281 | 0.020 |
Why?
|
| Facility Design and Construction | 1 | 2011 | 3 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 38 | 0.020 |
Why?
|
| Contract Services | 1 | 2011 | 2 | 0.020 |
Why?
|
| Paint | 1 | 2011 | 5 | 0.020 |
Why?
|
| Health Services | 1 | 2012 | 62 | 0.020 |
Why?
|
| Ownership | 1 | 2011 | 12 | 0.020 |
Why?
|
| Food Analysis | 1 | 2011 | 34 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 126 | 0.020 |
Why?
|
| Women's Health Services | 1 | 2011 | 12 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2012 | 117 | 0.020 |
Why?
|
| Urban Health | 1 | 2011 | 99 | 0.020 |
Why?
|
| Dust | 1 | 2011 | 55 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 146 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 58 | 0.020 |
Why?
|
| Consensus | 1 | 2010 | 53 | 0.020 |
Why?
|
| Telefacsimile | 1 | 2010 | 1 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 145 | 0.020 |
Why?
|
| Food Dispensers, Automatic | 1 | 2010 | 4 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2010 | 16 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2010 | 21 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 72 | 0.020 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2010 | 39 | 0.020 |
Why?
|
| Nutritive Value | 1 | 2010 | 37 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 163 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 725 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2009 | 62 | 0.020 |
Why?
|
| Adhesiveness | 1 | 2009 | 5 | 0.020 |
Why?
|
| Health Personnel | 1 | 2012 | 262 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2009 | 33 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 40 | 0.020 |
Why?
|
| Aspirin | 1 | 2010 | 88 | 0.020 |
Why?
|
| Fasting | 1 | 2009 | 56 | 0.020 |
Why?
|
| Environment | 1 | 2010 | 148 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2009 | 48 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 82 | 0.020 |
Why?
|
| Policy Making | 1 | 2008 | 35 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 482 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2009 | 99 | 0.020 |
Why?
|
| Tunica Media | 1 | 2008 | 14 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2008 | 21 | 0.020 |
Why?
|
| Feedback, Psychological | 1 | 2008 | 11 | 0.020 |
Why?
|
| Body Image | 1 | 2008 | 87 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 102 | 0.020 |
Why?
|
| Placebos | 1 | 2007 | 41 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 113 | 0.020 |
Why?
|
| Metformin | 1 | 2008 | 74 | 0.020 |
Why?
|
| Community Networks | 1 | 2008 | 106 | 0.020 |
Why?
|
| Teaching | 1 | 2007 | 58 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 37 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2006 | 24 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 57 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 165 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2006 | 10 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 181 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 164 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 162 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 398 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 165 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 33 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 230 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 379 | 0.010 |
Why?
|
| Income | 1 | 2005 | 160 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2005 | 187 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2002 | 143 | 0.010 |
Why?
|